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F O R E W O R D
There has been a growing interest in the marine derived bioactivecompounds in the recent years, and the functional foods, enriched
with natural ingredients have been proved to provide beneficial action
for human health. Marine derived bioactive components and the functional food ingredients
demonstrated to possess potential health benefits. High value secondary bioactive
metabolites from the marine organisms are attracting attention because of the growing
demand for new compounds of 'marine natural' origin, having potential applications in
pharmaceutical fields, and concerns about the adverse effects by synthetic drugs and their
derivatives. The pioneering R & D works at ICAR-Central Marine Fisheries Research Institute
on marine bioprospecting envisaged a systematic approach involving chemical profiling of
major species of marine organisms for bioactive pharmacophore leads for activity against
various diseases, and a library of molecules with bioactive potential. The research work in
this institute developed protocols to prepare various pharmaceutical leads, nutraceuticals/
functional food supplements enriched with lead molecules with different properties against
various drug targets for use against various life-threatening diseases.
ICAR-Central Marine Fisheries Research Institute is the pioneering marine research
institute in India to work in the frontier area of bioactive molecule discovery from marine
organisms as promising therapeutic agents against various diseases, aquatic food product
technology, and development of high value products for health management. This prestigious
research institute of Indian Council of Agricultural Research is working in the broad national
interest of producing high value bioactive leads from the marine organisms, which would
provide promising therapeutic agents against various diseases. This institute has developed
and commercialized the nutraceutical products CadalminTM Green Algal extract (CadalminTM
GAe) and Antidiabetic extract (CadalminTM ADe) as green alternatives to synthetic drugs to
combat rheumatic arthritic pains and type-2 diabetes, respectively to a leading
biopharmaceutical company in India. The anti-inflammatory nutraceutical Cadalmin™ Green
Mussel extract (Cadalmin™ GMe) from Asian green mussel Perna viridis has been
commercialized with Amalgam Group of Companies. CadalminTM Antihypercholesterolemic
extract (CadalminTM ACe) has been developed from seaweeds to combat dyslipidemia leading
to obesity, and the product was out-licensed to a leading Indian MNC in wellness and
obesity management. Antimicrobial therapeutic product from marine bacteria as oral
applicant has been developed and the product is in pipeline for commercialization. Seaweed-
derived natural template inspired synthetic derivatives as potential pharmacophores were
designed and developed. Several nutraceutical and cosmeceutical products from marine
organisms are in pipeline, and are being commercialized.
The objective of the National level ICAR Winter School on "Recent advances in bioactive
compounds from marine organisms and development of high-value products for health
management" is to provide up-to-date information and acquaint the participants with the
latest technologies on isolation and characterization of marine natural products of
pharmaceutical importance from marine organisms, general and advanced methods of
isolation procedures by chromatography, classification of organic compounds and their
characterization by advanced spectroscopic experiments. This program further aims to give
exposure to the chemical perspectives of marine organisms, primary and secondary bioactive
metabolites from fish and marine organisms to develop bioactive compounds and high-
value functional food products. Theory and practical classes will be conducted in these
areas to provide the participants a hands-on experience.
This ICAR Winter School is organized with the full funding support from ICAR, New
Delhi, and the twenty-five participants from various parts of India who are attending this
programme were selected after scrutiny of their applications based on their bio-data. They
are serving as academicians, such as Professors/Scientists, and in similar posts. The faculties
include the knowledgeable scientists and professors from various parts of India and abroad.
This training will enable the participants to efficiently carry out their academic programmes,
and to plan research on bioactive molecule discovery in their respective laboratories and
institutes so that they can formulate the strategies for research.
The Winter School on "Recent advances in bioactive compounds from marine organisms
and development of high value products for health management" is very ideal for the
current scenario of increasing lifestyle diseases and human health. Understanding the
importance of natural products in the health care system of India, ICAR-Central Marine
Fisheries Research Institute has reasonably contributed in the various aspects. The Manual
released on this occasion covers all aspects of marine natural products prepared by the
experts in their respective fields. I congratulate the Course Director of this programme, Dr.
Kajal Chakraborty and Head of the Marine Biotechnology Division, Dr. P. Vijayagopal, along
with other staff members of Marine Biotechnology Division and Central Marine Fisheries
Research Institute for their sincere efforts in bringing out the manual in time, and to arrange
the programme in a befitting manner.
A. Gopalakrishnan
Director, ICAR-Central Marine Fisheries Research Institute
Kochi, Kerala
P R E F A C E
Marine-derived bioactive components and the functional food ingredients with potentialhealth benefits are an emerging area of research. The rich diversity of flora and fauna
in the marine and coastal habitats of the Indian subcontinent represent an untapped reservoir
of bioactive compounds with valuable pharmaceutical and biomedical use. Considering the
underutilization of these groups of marine organisms, exploring bioactive compounds and
development of any biologically useful products have benefits as health products.
Comprehensive analyses demonstrated that during the last decade the average proportion
of bioactive compounds among the new compounds is declining, though there are a large
number of marine natural products yet to be explored. This may indicate that the research
level of bioactivity is not keeping up with the discovery of new compounds. Thus, the research
tools and methods for finding bioactivity need to be improved. The first improvement is
about methods of spectral and bioactivity-guided separation and purification of marine-
derived secondary metabolites, which combine the discovery of new compounds. These
improvements in technology are dependent upon the automation in spectroscopy, which
also allows the study of the functions of new compounds extracted from the target marine
organisms. Second, for the discovery of new lead compounds and artificial intelligence for
drug development evolved to a more mechanistic approach that targets specific molecular
lesions. Combined with high-throughput screening through a large number of drug targets,
bioactivity research against various life-threatening diseases will be effective in revealing
the potentially useful biological properties of marine natural products. Furthermore, the
discovery of new bioactive compounds from marine metabolites will form the basis for new
drug leads. Thus, the new compounds will absolutely compose an abundant resource for
future bioactivity research and drug development. Various medicinal and biomedical products
from marine flora and fauna provide a myriad of benefits for human health and multiple
life-threatening diseases, and therefore, are the attractive options for the food and
pharmaceutical industry. The increasing interest in marine-based functional food ingredients
and nutraceutical formulations in the last decade along with increased number of patents
filed/granted have appropriately demonstrated the possibilities of bioactive from marine
organisms to maintain and improve human health and well-being.
The present ICAR Winter School on "Recent advances in bioactive compounds from
marine organisms and development of high-value products for health management" is
designed to acquaint the participants with the advances in marine bioactive compounds
with emphasis on the latest technologies on isolation and characterization of marine natural
products of pharmaceutical importance. The course is planned in such a way that it covers
both theoretical and practical aspect of recent advances in bioactive compounds from marine
organisms. This programme will strengthen the knowledge of participants with regard to
the general and advanced methods of isolation procedures by chromatography, and their
characterization by advanced spectroscopic experiments aspects.
I wish to thank the Education Division of Indian Council of Agricultural Research for
giving us an opportunity to organize this ICAR Winter School. We are grateful to Dr. A.
Gopalakrishnan, Director, ICAR-Central Marine Fisheries Research Institute, for his guidance,
continuous interest in the course and providing all necessary facilities. I am highly obliged
to Dr. P. Vijayagopal, Head, Marine Biotechnology Division for his guidance and support for
the programme. All the scientists of Marine Biotechnology Division, technical staff, supporting
staff and research scholars supported us in organizing the ICAR Winter School. I recall with
gratitude the marvellous effort and help in preparing this manual by Minju Joy, Research
Scholar of Marine Biotechnology Division. I take this opportunity to thank all the faculty
members who have devoted their valuable time and contributed material for the preparation
of the manual. I am confident that the Course Manual would aid the participants to enhance
their knowledge and competence in the area of marine bioactive compounds and their
applications for the development of high-value products for health management.
Kajal Chakraborty
January, 2018 Course Director
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Enthusiasm of the scientific community towards the discovery of new drug leads from
marine habitats is unquenchable. Marine natural products have been recognized as a source
of highly desirable chemodiversity to support drug discovery and pharmacology applications
by the diverse chemical features and the wide range of biological activities possessed by
them. According to the latest review by Blunt et a,l., 1378 new compounds were isolated
from marine organisms in 2014 compared with 332 in 1984 (Blunt et al., 2016; Faulkner,
1994). Marine flora and fauna play a momentous role as a foundation of new molecular
entity. Over 5 million species of the world in about 30 different phyla reside in the oceans.
Because of the diversities of marine organism and habitats, marine natural products enfold
a wide variety of chemical classes, including Terpenes, Shikimates, Polyketides, Acetogenins,
Peptides, and Alkaloids of varying structures and multitude of compounds of mixed
biosynthesis. These natural products are secondary metabolites and enhance survival fitness
and may serve as chemical weapons used against bacteria, fungi, viruses and small or large
animals. A good number of the natural products of interest to the pharmaceutical industry
are secondary metabolites and several such compounds, derived from marine organisms,
have been in clinical trials as experimental drugs. Over the past 50 years, numerous novel
compounds have been isolated from marine flora and fauna having biological activities
such as antibacterial, antiviral, antitumor, antiparasitic, anticoagulants, antimicrobial, anti-
inflammatory and cardiovascular compounds.
BIODIVERSITY OF MARINE ENVIRONMENT - A SOURCE OF CHEMICAL DIVERSITY
Marine environment is a natural habitat for a broad variety of living organisms having
different physiology and capacity to adapt their environment. Out of over 33 animal phyla
known today, a total of 32 phyla are embodied in the marine environment out of which 15
varieties are exclusively present in the marine environment (Margulis and Schwartz, 1998).
The marine environment provides different biosynthetic conditions to organisms living in it.
Such genetic diversity renders chemical diversity which is promising for new drug
development. Highly stressed oceanic conditions, including a combination of light and O2,
was reported to trigger oxidative stress in marine species, including molluscs and seaweeds,
generating the formation of ROS and other strong oxidizing agents (Dykens et al., 1992).
However, absence of oxidative damage in structural components, their stability to quench
toxic ROS suggest that their cells are equipped with a powerful anti-inflammatory and
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antioxidant system (Jiménez-Escrig et al., 2001). Seaweed species collected from the coasts
of Quintana Roo and Yucatan showed antioxidant and anti-inflammatory activities, suggesting
that tropical macroalgae develop an effective antioxidant defense system due to strong UV
radiation in tropical environment.
CHEMISTRY OF MARINE NATURAL PRODUCTS
Marine natural products chemistry has passed through several phases of development.
The collection of materials from deep seas has been made trouble-free by scuba diving.
Many potent compounds have been provided in pure form by effective methods of isolation.
Many intricate structural and stereochemical problems have been solved by advanced
instrumentation methods such as nuclear magnetic resonance, mass spectrometric
techniques and X-ray diffraction. The present section is a minor effort to throw light into
readers regarding bioactive marine natural products. There is no inappropriate claim that a
comprehensive coverage of all bioactive compounds has been made. Nevertheless efforts
have been taken for not excluding any of the major class of bioactive compounds.
BIOACTIVE SECONDARY METABOLITES OF MARINE ORGANISMS
BIOACTIVE MARINE STEROLS
Sterols, also known as steroid alcohols, are a subgroup of steroids, which are ubiquitously
found in marine invertebrates, plants, and fungi. Sterols from marine sources have been
reported to possess diverse bioactivities, including antiproliferative, cytotoxic, anti-fouling,
and farnesoid X-activated receptor antagonistic activities (Ioannou et al., 2009; Shin et al.,
2012). 5a,8a-Epidioxysterols have been reported to possess growth inhibiting activity against
human cancer cells from lung denocarcinoma, gastric carcinoma, promyelocytic leukemia,
colon adenocarcinoma, myelogenous leukemia, nasopharyngeal carcinoma, breast
adenocarcinoma, liver adenocarcinoma, and acute monocytic leukemia (Sheu et al., 2000;
Gauvin et al., 2000; Takei et al., 2005; Pan et al., 2006). 5a,8a-epidioxysteroids (4.1a)  with a
double bond between C-24 and C-28 (a terminal vinyl group) isolated from a marine sponge
of the genus Monanchora offer potential leads for the discovery of new antipancreatic
cancer agents.
There has been a report of isolation of a phytosterol 24-propylidene-cholest-5-en-3–ol
(4.1b) (24-branched Ä5 sterols) from extract of red seaweed L. papillosa as antibacterial
agent (Kavita et al., 2014). The sterols from marine algae are reported to be non-toxic and
have the ability to reduce blood cholesterol level. They are also reported to reduce the
tendency to form a fatty liver and excessive fat deposition in the heart (Heinemann et al.,
1991). Sterols with unusual structural features such as 5,6-epoxy-(22E,24R)-3,11-dihydroxy-
9,11-secoergosta-7-en-9-one (4.1c)  was isolated from Gorgonian corals belonging to the
genus Pinnigorgia which displayed inhibitory effects on the generation of superoxide anions
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and the release of elastase by human neutrophils.
Asterosaponins are sterol derivatives of echinoderm and reported to have hemolytic,
antineoplastic, cytotoxic, antitumor, antibacterial, antiviral antifungal and anti-inflammatory
activities. (Leung and Stefano, 1983; Leung and Stefano,1984). The novel neuritogenic steroid
glycosides Linckosides A and B (4.1d) were isolated from the Okinawan starfish Linckia
Laevigata. It was reported that a novel sterol, which isolated from marine sponge
Actinomadura sp. SBMs009, showed the translocation inhibition of NF-kB at the half maximal
inhibitory concentration (IC50) of 71µM. The inhibition of NF-kB translocation suggested
that Bendigole F (4.1e) has potential anti-inflammation activity (Simmons et al., 2011).
Sterol glycoside Carijoside A (4.1f) which isolated from octocorals belonging to genus
Carijoa (=Telesto), had shown the anti-inflammatory activity, significant inhibition of
superoxide anion generation (IC50=1.8 µg/ml), and elastase release (IC50=6.8 µg/ml) by human
neutrophils (Liu et al., 2010). 3-Hydroxy-26-norcampest-5-en-25-oic acid (4.1g)  from
Euryspongian sp. was reported that it has effect on COX pathway and thus could be a
potential anti-inflammatory natural compound derived from marine sponge (Mandeaua et
al., 2005). It has been reported that isolated sterol from sponge Dysidea arenaria, 9a,11a-
epoxycholest-7-ene-3b,5a,6a,19-tetrol-6-acetate (ECTA) (4.1h), showed the enhancement
in antifungal activity when combined with fluconazole, one common antifungal drug.
Fluconazole alone showed IC50=300 µMon drug resistance Candida albicans; however, the
IC50 of fluconazole is decreased to 8.5µM when combined with 3.8 mM of ECTA (Jacob et al.,
2003). Sterols from the Red Sea marine sponge Lamellodysidea herbacea, cholesta-8,24-
dien-3b,5a,6a-triol and cholesta-8(14),24-dien-3b,5a,6a-triol, also showed the antifungal
activity against Candida tropicalis (Sauleau and Bourguet-Kondracki, 2005). The sulfated
sterol ibisterol (4.1i) was isolated from the deep water Caribbean sponge Topsentia sp. that
was investigated as anti-HIV agent (McKee et al., 1993). Sun et al., (1991) reported that
weinbersterol disulfates A (4.1j) was isolated from the sponge Petrosia weinbergi, which is
active in vitro against HIV. Clathsterol (4.1k) isolated from Red Sea sponge Clathria sp.
inhibit HIV-1 reverse transcriptase activity at a concentration of 10 µM (Rudi et al., 2001).
Studies on sterols isolated from marine sponge have shown that ibisterol sulfate from
Topsentia sp., halistanol sulfate (4.1l) from Halichondria cf. moorei, and 26-methylhalistanol
sulfate and 25-demethylhalistanol sulfate from Pseudaxinyssa digitata showed essentially
complete protection against the cytopathic effects of HIV-1 infection at half maximal effective
concentration (EC50) of 13, 6, 3, and 6 mM, respectively. Two sterols 5a,6a-epoxy-24R-
ethylcholest-8(14)-en-3b,7a-diol and 5a,6a-epoxy-24R-ethylcholest-8-en-3b,7a-diol purified
from marine sponge Polymastia tenax showed antiproliferative activity toward lung (A549),
colon (HT-29 and H-116), mice endothelial (MS-1), and human prostate carcinoma (PC-3)
cell lines (Santafe´ et al., 2002). Orostanal (4.1m), purified sterol from marine sponge Stellatta
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hiwasaensis inhibited proliferation in human leukemia (HL-60) cell line at IC50 1.7 mM
(Miyamoto et al., 2001).
Lobophytosterol from soft coral Lobophytum laevigatum showed cytotoxicity effect on
A549 and HL-60 with IC50 values of 4.5 and 5. mM, respectively. The new compounds 5b,6b-
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epoxyergost-24(28)-ene-3b,7b-diol, together with the known compound ergost-24(28)-ene-
3a,5b,6b-triol, exhibited strong and selective cytotoxicity against the HT-29 cell line with an
ED50=0.1 µg/ml, and an ED50=0.25 µg/ml for ergost-24(28)-ene-3b,5a,6b,7b-tetrol (Rueda
et al., 2001). Purified armartnol A (4.1n) from soft coral Nephthea armata exhibited cytotoxicity
against A549, HT-29, and P-388 (mouse lymphocytic leukemia) cell lines with IC50 value of
7.6, 6.5, and 6.1 mM, respectively. Moreover, armartnol B (4.1n) showed cytotoxicity against
P-388 and HT-29 cells with IC50 values of 3.2 and 3.1 mM, respectively (El-Gamal et al., 2004).
Wang et al., (2004) reported that certonardosterol Q6 (4.1o) from starfish Certonardoa
semiregularis exhibited cytotoxicity effect on A549, SK-OV-3 (human ovarian cancer), SK-
MEL-2 (human skin cancer), and HCT 15 cell line at ED50 values of 0.43, 0.22, 0.17, and 0.48
mg/ml, respectively. On the whole, sterols from marine resources have potential in
development of anticancer agents.
BIOACTIVE TERPENOIDS
These compounds are derived from a five-carbon isoprene structure, and depending
on the combination of units, can be subdivided into biogenetic classes such as monoterpenes,
sesquiterpenes, diterpenes, sesterpenes, triterpenes (steroids), and tertraterpenes
(carotenoids). The green algae of the genera Halimeda, Penicillus and Udotea are found to
contain highly active but unstable sesquiterpenoids and diterpenoids. Some of these
diterpenoids exhibit cytotoxic and antimicrobial activities (Paul, 1984; Tillekeratne, 1984).
Manoalide (4.2a) is sesquiterpenoid isolated from the Indo-Pacific sponge Luffariella variabilis.
Manoalide which contains an á,â-unsaturated ã-lactone function, had antiinflammatory
activity and was found to be an inhibitor of phospholipaseA2 (Freita and Jacob,1984). Tsukada
et al., (2011) isolated the decarboxyhydroxycitrinone (4.2b), a terpene, from the marine
fungus Arthrinium sacchari, with antiangiogenic activity. The pseudopterosins (4.2c) are
tricyclic diterpene glycosides isolated from the Caribbean Sea whip (gorgonian)
Pseudopterogorgia elisabethae (Gorgoniidae). They are potent anti-inflammatory and
analgesic agents and appear to inhibit eicosanoid biosynthesis by inhibition of both PLA2
and 5-lipoxygenase. The pseudopterosins have been licensed to a small pharmaceutical
firm, OsteoArthritis Sciences Inc., for medical use as potential anti-inflammatory drugs.
However, the pseudopterosins extract has found its way to the marketplace. It is used as an
additive to prevent irritation caused by exposure to the sun or the chemicals in the Estée
Lauder cosmetic skin care product, Resilience.
Sesquiterpene africanene (4.2d) isolated from the soft coral Sinularia leptoclados resulted
in a more potent reduction of paw volume than that produced by 100 mg/kg body weight
of ibuprofen, in carrageenan-induced rat edema assay. A novel sesterterpene
Cacospongionolide B (4.2 e) isolated from the sponge Fasciospongia cavernosa was  found
to be an inhibitor of human synovial phospholipase A2. It irreversibly inhibited both secretory
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PLA2 in vitro and group II secretory PLA2 in vivo. Sesquiterpenes capillosanane A (4.2f)
isolated from Sinularia capillosa (Sanya Bay, Hainan Province, China) (Cheng et al., 2013)
exhibited antifouling activity against B. amphitrite.
BIOACTIVE MARINE ALKALOID
Three alkaloids having an unusual decahydroquinoline skeleton and showing significant
and selective antiplasmodial and antitrypanosomal activity were obtained from a new tunicate
species of the genus Didemnum (Wright et al., 2002) These bioactive alkaloids may serve as
lead structure for the development of new antimalarial drugs. Lamellarin á20 sulfate (4.3a),
an ascidian alkaloid inhibited HIV-1 integrase of virus in cell culture (Reddy et al., 1999). Two
steroidal alkaloids, plakinamine A (4.3b) and plakinamine B (4.3c) which could act as
antimicrobial metabolites by inhibiting the growth of Staphylococcus aureus and Candida
albicans were obtained from Plakina spp. of marine sponges (Roser and Faulkner, 1984).
The compounds Pyridoacridines (4.3d) are alkaloids that have a common tetracyclic
heteroaromatic parent-pyrido [4,3,2-m,n]acridine  system. The yellow tunicate Cystodytes
dellechiajei from Okinawa has yielded nine cytotoxic tetracyclic pyridoacridine alkaloids
named cystodytins (4.3e) (Kobayashi et al., 1991).
Two new bromopyrrole alkaloids, nagelamides M (4.3f) and N(4.3g), which displayed
antimicrobial activity have been isolated from an Okinawan marine sponge Agelas species
(Kubota et al., 2008). The ascidian Eudistoma olivaceum is an extraordinary rich source of
tryptophan derived alkaloids. Several alkaloids named eudistomins having a â-carboline
system and significant antiviral activity had been isolated from this source (Rinehart, 1987).
Significant antiviral activity was observed for a series of indole alkaloids, Eudistomin-C 153
(4.3h) from Tunicate Eudistoma olivaceum being most effective against Human Simplex
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Virus. An alkaloid Lamellarin D (LAM-D) (4.3i) initially isolated from a prosobranch mollusk
of the genus Lamellaria, exhibits cytotoxicity against many different tumors.
The Xestospongins (4.3j and 4.3k) (from Australian sponge Xestospongia exigua) (Orabi
et al., 2002) represent a new class of macrocyclic alkaloid incorporating two 1-oxaquinolizidine
rings and were reported as vasodilative compounds which induce relaxation of blood vessel
in vivo. Ptilocaulin (4.3l) and isoptilocaulin (4.3m) isolated from Ptilocaulistaff and P. spiculifer
(Cafieri  et al., 1998) exhibit high order of antimicrobial activity against Grampositive and
Gram-negative bacteria, and also inhibit cell growth against L 1210 leukemia cells.
Tyrindoleninone (4.3n) and 6-bromoisatin (4.3o) are indole derivatives from marine mollusk
Dicathais orbita that induces apoptosis in female reproductive cancer cell lines ovary,
granulosa, and choriocarcinoma (OVCAR-3, KGN, Jar), respectively (Edward et al., 2012).
Ecteinascidin-743 or ET-743 (4.3p) is a tetrahydroisoquinoline alkaloid derived from the
colonial tunicate Ecteinascidia turbinata, a sea squirt that lives in clusters in the Caribbean
and Mediterranean seas. Early on, the compound demonstrated very potent activity against
a broad spectrum of tumor types in animal models (Reinhart, 2000).
BIOACTIVE MARINE PEPTIDES
Aplidine (4.4a), a marine depsipeptide from Mediterranean tunicate Aplidium albicans
was in phase-II clinical trial (Earbo et al., 2002). Aplidine in human Molt-4 leukaemia cells
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was found to be cytotoxic at nanomolar concentrations.
Dolastatin 10 (4.4b) is a linear peptide isolated from the sea hare Dollabella auricularia
from the Indian Ocean and is a well known antitumour agent with ED50 = 0.046 ng/ml
against P 388 cells. Dolastatin 15, a potent antineoplastic peptide from the mollusk Dolabella
auriculata was undergoing clinical trials in Europe and North America (Hu et al., 1999)
Vitilevuamide (4.4c) a bicyclic peptide was isolated from marine ascidians Didemnum
cuculiferum and Polysyncranton lithostrotum. The peptide was cytotoxic in several human
tumor cell lines with IC50 values ranging from 6 to 311 nM. Haliclona sp. a marine sponge
yielded kendarimide A (4.4d), a novel peptide which reversed glycoprotein mediated
multidrug resistance in tumor cells. Two new cyclic depsipeptide derivatives, Kahalalides R
and S, together with two known congeners, Kahalalides F (4.4e) and D, were isolated from
the Indian sacoglossan mollusk Elysia grandifolia (marine gastropod mollusks). The new
derivative Kahalalide R was found to exert comparable or even higher cytotoxicity than the
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potential drug candidate kahalalide F toward the MCF7 human mammary carcinoma cell
line.
Didemnin B (4.4f) is one of a number of related depsipeptides isolated from the
Caribbean tunicate Trididemnum solidum (Didemnidae). It was later found to display
antineoplastic, antiviral and subsequently immunosuppresive activities (Rinehart 1988). A
close relative of didemnin B- dehydrodidemnin B, isolated from a Mediterranean tunicate
Aplidium albicans, is currently in Phase II studies in the United States and Europe, to determine
its anticancer properties.
Ziconitide (4.4g) is a 25 aminoacid peptide from the venom of a predatory snail Conus
magnus. It acts by binding to and inhibiting presynaptic calcium channels, thereby preventing
neurotransmitter release. It is licensed by Elan Pharmaceuticals under the name Prialt.
POLYSACCHARIDES
Sulfated polymannuroguluronate (SPMG), a marine sulfated polysaccharide entered in
phase II clinical trial in China as the first AIDS drug (Miao et al., 2004). A new polysaccharide
exhibiting anti-HIV activity and made up of galactan sulfate was isolated from the marine
clam Meretrix petechialis (Amornrut et al., 1999). The antiviral activity observed in green
algae Codium elongatum and the two species of Hypnea was attributed to the polysaccharides
(Kamat et al., 1992). Carrageenans from Chondrus crispus is known to be antiviral. The activity
has been reported to be due to the sulphated galactose unit of the phycocolloid. Algal
polysaccharides such as laminarin, fucoidan, and algin, which lack sulfated galactose unit
exhibit no antiviral activity.
BIOACTIVE ACETOGENINS
Acetogenins are a large cluster of nonterpenoid molecules that derive in the polyketide
pathway (Dembitsky et al., 2003). They are relatively widespread in certain plant families,
particularly Annonaceae, and are renowned for their biological activities. Acetogenins derived
from annonaceous are larger molecules (C35 or C37) bearing ether groups (Liaw et al., 2010)
and in seaweeds, acetogenins are frequently halogenated, and are generally thought to
originate from a common C15 precursor (Wang et al., 2013). Acetogenins are recognized as
chemotaxonomic markers for marine algae (Kubanek, 2010). In spite of a few linear bioactive
compounds, most algal C15 acetogenins are cyclic ether metabolites with different ring sizes
and a conjugated enyne (C= C-C a” CH) or bromoallene (C= C=CHBr) terminus. Earlier
alkyne groups were considered to be rare in the nature, but now, it is well identified that
compounds with the acetylenic group are also common in seaweeds such as Petrosia sp
ranging from C44 to C47 (Minto and Blacklock, 2008). Acetogenins are recognized as
chemotaxonomic markers for red algae belonging to the family Rhodomelaceae, in particular,
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to the genus Laurencia (Stout and Kubanek, 2010). The most common biological activities
described for acetogenins include antibacterial activity towards different microorganisms.
The first reported acetogenins from Laurencia venusta venustin A (4.6a)  and B (4.6b)
(Suzuki and Kurosawa, 1980) which were renamed as 3-E-epoxyvenustin and 3-E-venustin
(Suzuki et al., 1983a), respectively. A related metabolite 3-Z-epoxyvenustin (4.6c), major
component comprising 10% of the extract, and also 3-Z-venustin (4.6d) and 3-Z-venustinene
(4.6e) were reported in Japan for a sample collected at Moura, near Asamushi, Aomori
Prefecture(Suzuki et al., 1983c)  Kaul et al., (2011) reported that the metabolites (4.6b)-
(4.6e) prolonged sleep-time in mice induced by pentobarbitone. 3-Z-dactylyne an acetogenin
of the hydropyran subclass, isolated from a Laurencia species from Japan (Suzuki et al.,
1999) presented pronounced activity in increasing blood levels of pentobarbital in a dose-
dependent manner. It increased both the half-life and the duration of action of the drug,
possibly due to the inhibition of metabolic elimination of pentobarbital caused by 3-Z-
dactylyne itself, or perhaps by a metabolite (Kaul and Kulkarni, 1978). Palaniveloo and
Vairappan (2014) collected samples of A.dactylomela from different islands of Malaysia, and
isolated 12-Z-lembyne A (4.6f), which was also reported for a non-identified Laurencia sp.
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from Malaysia (Vairappan et al., 2001a) and 12-E-lembyne A (4.6 g) which was also isolated
from L. mariannensis from Japan (Vairappan et al., 2001b). Both presented prominent
antibacterial activity against marine bacteria (Vairappan et al., 2001a, b). The isomer 3-Z-
chlorofucin isolated from L. elata (Dias and Urban, 2011) showed antibacterial activity against
Chromobacterium violaceum (Suzuki et al., 2001). Eight-membered cyclic ether acetogenins
laurencienyne (4.6h), were reported from algae collected in Sicily, was active against Bacillus
subtilis and Escherichia coli (Caccamese et al., 1980). Laurencia obtusa collected in the Saudi
Arabia Red Sea Coastal Jeddah also afforded acetogenins from the maneonene class: 12-Z-
cis-maneonene D (4.6i), 12-E-cis-maneonene E (4.6j), and 12-Z-trans-maneonene C(4.6k)
compounds (4.6i) and (4.6j) inhibited apoptosis of blood neutrophils, suggesting that they
may be involved in regulation of programmed death in the initiation and propagation of
inflammatory responses (Ayyad et al., 2011).
BIOACTIVE POLYKETIDES
Marine polyketides are a class of  natural compounds containing multiple â-
hydroxyketone or â-hydroxyaldehyde (-H2C(=O)CH2CH(OH)CH2C(=O)-) functional groups
that present remarkable biological properties. Due to the flexibility of their biosynthetic
production mechanism, these compounds exhibit remarkable diversity, in terms of structural
complexity. The marine polyketide Halichondrin B (4.7a) was isolated for the first time from
the sponge Halichondria okadai in 1986 along with other halichondrins and norhalichondrins
(Hirata et al., 1986; Aicher et al., 1992). Halichondrins display low nanomolar cytotoxic activity;
however, insufficient supply posed a problem for their further development.
Eribulin (4.7b) is an approved anticancer drug which is a synthetic derivative from
Japanese marine sponge Halichondria okadai. It acts by interfering with the microtubular
growth ultimately leading to apoptosis after prolonged mitotic blockage. Bryostatins (4.7c)
are a family of polyketide compounds that shows remarkable in vitro and in vivo anticancer
activity with no significant side effects (Hale et al. 2002). The first members of the bryostatin
family were isolated by Pettit and co-workers in 1968 from the invertebrate bryozoans
Bugula neritina and Amathiaconvulata. The didemnin family of polyketides was isolated
from the Caribbean tunicate Trididemmum solidum in 1981 (Rinehart et al., 1981).  Didemnin
B (4.7d) was the most potent analog of this series of compounds and entered clinical trials
as an anticancer agent. Nevertheless, this compound showed cardiac and neuromuscular
toxicities and the clinical process was put to halt. The family congener aplidine (4.7e)
(plitidepsin) was later isolated from the Mediterranean tunicate Aplidinium albicans (Urdiales
et al., 1996) which displayed a similar pharmacological profile but less toxicity, and replaced
didenmin B in multiple phase I and phase II trials as an anticancer agent ( Lee et al., 2012).
Salinosporamide A (4.7f) (marizomib; NPI-0052) is ã-lactam-â-lactone isolated by Fenical,
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Jensen and co-workers from the bacteria Salinosporatropica, which are found in marine
sediment collected in the Bahamas (Feling et al., 2003). It is a novel, potent proteasome
inhibitor. It induces apoptosis by a caspase-8 dependent mechanism in multiple myeloma
and leukemia cells. The spongistatins are a family of marine polyketide macrolides with
highly complex structures and interesting anticancer properties. Among this family of natural
products, Spongistatin 1 (4.7g) is the most interesting macrocycle because of its extraordinary
biological activity. Spongistatin 1 was isolated by Pettit and co-workers from sponges
Spirastrella spinispirulifera and Hyrtios (Pettit et al., 1993; Schwarzenberg et al., 2013). (+)-
Discodermolide (4.7h) was isolated by Gunasekera and co-workers from the Bahamian deep
water sponge Discodermia dissolute (Gunasekhara et al., 1990). The first biological activity
investigation of (+)-Discodermolide was related to its strong immunosuppressive effect
(De souza, 2004).  It was later also recognized as a cytotoxic agent. (+)-Discodermolide is an
antimitotic agent which produces disruption of cellular division by microtubule stabilisation.
(+)-Discodermolide is often compared to Taxol® (Paclitaxel), a widely used drug in
chemotherapy. Both drugs present a similar tubulin-binding mechanism; however, (+)-
discodermolide has been described to be more potent and to have higher affinity than
paclitaxel. The sponge Lithoplocamialithistoides from Madagascar was the source of two
new polyketide compounds: PM060184 (4.7i) and its chloride derivative PM050489 (4.7j)
isolated by PharmaMar. Currently PM060184 is undergoing phase I clinical trials in late
stage cancer Patients (Pera et al., 2013).
Marine polyketides in the clinical pipeline.
Compound Structure Target Clinical Disease
status Area Company
Eribulin Macrocyclic PK Microtubules Approved Cancer Eisai Co., Ltd.
(2010)
Bryostatin Institute Macrocyclic PK Protein kinase C Phase I-II Alzheimer National Cancer
Aplidine Macrocyclic Protein Kinases Phase I-III Cancer PharmaMar S.A.
mixed PK-NRP
PM060184 Linear PK Microtubules Phase I Cancer PharmaMar S.A.
Salinosporamide A γ-lactam- 20S Phase I Cancer Triphase A.C.
β-lactone proteasome
mixed PK-NRP
Spongistatin Macrocyclic PK Tubulin Preclinical Cancer National Cancer
Institute
Discodermolide Linear PK Microtubules Discontinued Cancer Novartis A.G.
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Polyacetylenes
Acetylene compounds or “polyacetylenes” are a general name for a substantial class of
natural products,2 of which all contain one or more carbon”carbon triple bond functionalities
in their molecules. Several polyacetylenes exhibiting significant selective cytotoxicity against
human tumor cell lines were isolated from the marine sponge Petrosia sp. (Kim et al., 2002).
Marine organisms are a great source of polyacetylenes. Among marine organisms, sponges
are the main source of polyacetylenic compounds. Several polyacetylenes exhibiting
significant selective cytotoxicity against human tumor cell lines were isolated from the marine
sponge Petrosia sp. (Kim et al., 2002). The symmetric metabolite petrosynol (4.8a) and
petrosolic acid (4.8b) were isolated from a Red Sea Petrosia sp. by Isaac et al., (1993). Petrosolic
acid is notable because C44 carboxylic acids are relatively rare in natural products chemistry.
Petrosynol inhibited the cell division of sea urchin eggs and petrosolic acid inhibited DNA
polymerase activity of HIV reverse transcriptase (Isaac et al., 1993). Dideoxypetrosynol A
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(4.8c), obtained from the marine sponge Petrosia sp., shows significant selective cytotoxic
activity against several human cancer cell lines (Park et al., 2007). The petroacetylene  (4.8d),
a C30 linear polyacetylene isolated from the Japanese marine sponge Petrosia solida, inhibited
blastulation of starfish embryos at a concentration of 3.1 ìg/mL or greater (Ohta et al.,
2013). Nepheliosyne A (4.8e) is the first polyacetylene isolated from Xestospongia sp. by
Kobayashi et al., (1994) is one of the longest marine acetylenic acids with a C47 chain length
(Fig. 13). Nepheliosyne A exhibited a weak in vitro cytotoxicity against L-1210 lymphoma
and human epidermal carcinoma KB cells (IC50 > 20 ìg/mL) (Kobayashi et al., 1994). The
acetylenic 3-alkylpyridines hachijodines F (4.8f) and G (4.8g), xestamine A (4.8h), and
niphatyne A (4.8i) were found in Xestospongia and Amphimedon sponges (Fig. 15) (Sakemi
et al., 1990; Quinoa and Crews, 1987; Tsukamota et al., 2000). They bear long alkyl chains
terminated by N-methoxy-N-methylamino or N-methylhydroxylamino substituents. The
hachijodines were found to have cytotoxicity against P388 murine leukemia cells (1.0 ìg/
mL). Micronesian Xestospongia cave sponge was the source of three polyacety-lenes (4.8j1-
4.8j3) with low ìM activity against Pseudomonas aeruginosa (Ankisetty, 2012). Niphatynes A
and B (4.8k1, 4.8k2) were the first metabolites with the 3-alkylpyridine skeleton isolated
from marine sponges. Niphatyne A exhibited a cytotoxic activity against leukemic cells
P388 (IC50=0.5 ìg/mL) (Quinoa and Crews, 1987) (Fig. 17). The linear C36 diacetylenic alcohol,
lembehyne A (4.8l), was isolated from an Indonesian Haliclona sp. (Aoki et al., 2001).
Lembehyne A induced neurite outgrowth of rat pheochromocytoma PC12 cells at a minimal
concentration of 2 mg/mL and induced neuritogenesis in mouse neuroblastoma Neuro 2A
cells at 0.1 mg/mL. Isolated from Callyspongia truncata, callyspongynic acid (4.8m) contains
the á,â-acetylenic acid and the 4-en-1-yn-3-ol termini. Callyspongynic acid is a specific
inhibitor of á-glycosidase (IC50 0.25 µg/mL) (Fig. 23). A macrolide, callyspongiolide (4.8n),
was isolated from the marine sponge Cal-lyspongia sp. collected in Indonesia (Pham et al.,
2014).
Callyspongiolide showed strong cytotoxicity against human Jurkat J16 T and Ramos B
lymphocytes, with IC50 values of 70 and 60 nM, respectively, after 48 h of treatment. The
EtOAc extract of the sponge Callyspongia sp. showed significant activ-ity against human
promyelocytic leukemia cells (HL-60). Further bioassay-guided fractionation of the EtOAc
extract led to the isolation of three polyacetylene metab-olites: callyspongidiol (4.8o) (28A)
(Umeyama et al., 2010), siphonodiol (4.8 p) and 14,15-dihydrosiphono-diol (4.8 q)  (Masao
et al., 2008). They exhibited antiproliferative activity against HL-60 with IC50 values of 6.5,
2.8, and 6.5 µg/mL, respectively. HIV-1 integrase inhibition assay used in the bioguided
purification of Diplastrella spp. extracts allowed the identification of diplynes A-E (4.8r1-
4.8r4) , jointly purified with diplyne A 1-sulfate  (4.8r5) , diplyne C 1-sulfate (4.8r6), and
deoxydiplyne D sulphate (4.8r7); only sulfated compounds were bioactive (Lerch et al., 2003).
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Namenamicin  (4.8 u)  (McDonald et al.,1996) and shishijimicins A-C (4.8v1-4.8v3) (Oku et
al., 2003) showed interesting cytotoxic properties have been isolated from the ascid-ians
Polysyncraton lithostrotum and Didemnum proliferum, respectively.
SHIKIMATES
Shikimates are metabolite derivatives from the shikimate pathway, produced by bacteria,
fungi, plants, and some protozoaroans for the biosynthesis of some aromatic amino acids,
such as L-phenylalanine, L-tyrosine, and L-tryptophan. This pathway is not present in animals,
and the shikimate-derived aromatic ami-no acids have been obtained through diet.
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Chrysophaentin A was isolated by Plaza et al., (2010) from the
marine chrysophyte alga Chrysophaeum taylori and tested against
several multiresistant bacteria, including methicilin-resistant
Staphylococcus aureus, multidrug resistant Staphylococcus aureus,
and vancomycin-resistant Enteroccocus faecium.
BIOACTIVE MARINE TOXINS
The chemistry of the toxins is imperative to devise proper
counter measures, such as detection, determination and
therapeutic methods. It is important to understand their
mechanism of action at molecular level. Many of the toxins have
been found to be useful tools for probing biological or pharmacological phenomena, such
as use of tetrodotoxin in sodium channel studies,1 and okadaic acid in protein phosphatase
studies (Bialojan and Takai, 1988). A team from the University of Melbourne has extracted
the conotoxin from a cone-shell snail which not only inhibits pain as being 10,000 times
more powerful than morphine, but also accelerates the recovery of injured nerves (Holmes,
2002). Aplysiatoxins and oscillatoxins isolated from blue-green algae Schizothrix calcicola
and Oscillatoria nigroviridis possess antileukaemic activity but their high toxicity precludes
their medicinal use. Anatoxin-a, an exogenic toxin of blue-green alga Anabaena flosaquae
(Stjerulof et al., 1989) is one of the most potent nicotinic receptor agonist. Saxitoxin isolated
from algae Gonyaulax catenella blocks nerve conduction by specifically interfering with the
initial increase in sodium permeability of the membrane. The symptoms caused by the
toxin include peripheral paralysis. The saxitoxin compound isolated from algae have
biomedical application, with the neurotropic effect of saxitoxin use for important drugs
formation. Domoic acid also produced from algae have different pharmaceutical uses.
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Ciguatoxin and maitotoxin both groups of toxins are produced by the epiphytic dinoflagellate
Gambierdiscus toxicus.
CONCLUSION
Marine natural products demonstrate compelling bioactivities and outstanding
pharmacological properties that make them well suitable for medical use. However their
complexities makes their supply difficult, along with their structural and stereochemical
assignment, which further decelerates their development as drug leads. Nowadays, the
main counter to overcome supply issues are either aquaculture of the producing organism
or the application of synthetic or semi synthetic methodologies to produce them in large
enough scale quantities. On the other hand, genetic engineering is starting to offer an
alternative for the production of certain metabolites. Aquaculture of marine invertebrates
can be used as supply route by finding the appropriate aquaculture conditions. This is the
most straightforward way to obtain gram quantities of a drug candidate in a short period of
time, but the fact that production is highly dependent on the external conditions and that
this can alter the production of some metabolites should be considered. Moreover,
aquaculture usually has an important environmental cost, as farms may have to be located
in oceans and the host.
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